Algert Global’s AYTU BioPharma AYTU Stock Holding History

Algert Global’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-132	Closed	-$31K	–	416
2020 Q3	$31K	Sell	132 -56	-30%	-$14.4K	0.01%	385
2020 Q2	$54K	Buy	+188	New	+$56.9K	0.02%	393

Other funds holding AYTU

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PSC

Piper Sandler & Co Minneapolis, Minnesota $102M AUM 0.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Algert Global's AYTU Position: Q4 2020 in Review

Algert Global sold out of AYTU BioPharma (AYTU) in Q4 2020, closing a stake of 132 shares — an estimated $31K sold.

Algert Global first reported a position in AYTU in Q2 2020 and held it in 2 quarters. The position peaked at $54K in Q2 2020. 42 funds tracked by Wall St. Rank hold AYTU as of Q4 2020.

Algert Global reported no remaining AYTU BioPharma position as of Q4 2020 after selling out during the quarter.
Algert Global sold 132 AYTU BioPharma shares in Q4 2020, an estimated $31K.
Algert Global first reported a position in AYTU BioPharma in Q2 2020 and held it in 2 quarters.
Algert Global's AYTU BioPharma position peaked at $54K in Q2 2020.
42 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2020.

Based on Algert Global's 13F filing for Q4 2020, filed 12 Feb 2021.